Interactive Investor
>>

Verona Pharma ADR (NASDAQ:VRNA) Share Price

VRNA

Verona Pharma ADR

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XNAS

-

Updated: -

Loading...

Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Verona Pharma PLC is a clinical-stage biopharmaceutical company. It is known for developing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.Verona Pharma PLC develops drugs for respiratory diseases. Its products mainly include anti-inflammatory agents and bronchodilators.

NASDAQ:VRNA

US9250501064

USD

Loading...

Loading Comparison

Latest VRNA News

Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News